Keep Factually independent
Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.
What active ingredients are in NeuroGold and what does research say about them?
Executive summary
NeuroGold is not a single, consistently defined product in the available reporting: an official “Neuro Gold” mushroom microdose capsule lists active ingredients per capsule as 200 mg Psilocybe cubensis, 125 mg Lion’s Mane, 125 mg Chaga and 50 mg ginger (manufacturer’s site) [1]. Other unrelated products use the “NeuroGold” name for a phosphatidylserine supplement (100 mg PS softgels) [2] [3] or a Manuka-honey nerve formula [4]; company profiles also associate Neurogold with CBD products [5]. Coverage is fragmented across different brands and formulations [1] [2] [4] [5].
1. What, precisely, is in the mushroom “Neuro Gold” product? — Manufacturer’s label
The product billed as “Neuro Gold Mushroom — Microdose Capsule” lists the active components per capsule as: Psilocybe cubensis (magic mushroom) fruiting bodies 200 mg, Lion’s Mane mushroom fruiting bodies (organic) 125 mg, Chaga mushroom fruiting bodies (organic) 125 mg, and organic ginger root 50 mg, with an explicit claim that fruiting bodies — not mycelium — are used [1]. The official shop and product pages repeat that ingredient list [1] [6].
2. Other products using the “NeuroGold” name — different actives, different claims
A separate product marketed as “NeuroGold Phosphatidylserine 100 mg” is a softgel formulation containing 100 mg phosphatidylserine per serving and excipients such as organic flaxseed oil, gelatin, vegetable glycerin, sunflower or soy lecithin, beeswax, caramel color and calcium carbonate [2] [3]. Yet another site promotes a NeuroGold-branded Manuka honey supplement that claims to target MMP‑13 and nerve myelin repair [4]. Corporate profiles also link “Neurogold” to CBD products from a Berlin-based company [5]. These are distinct products and should not be conflated [2] [1] [4] [5].
3. What does published research say about the ingredients listed in the mushroom formula? — Psilocybe cubensis, Lion’s Mane, Chaga, ginger
Available sources in this dataset document the ingredient list but do not provide primary scientific studies for each ingredient in the Neuro Gold mushroom product. The label shows Psilocybe cubensis (a psychedelic mushroom species) at 200 mg per capsule [1]. Broader research on CNS-active natural products indicates that flavonoids, terpenoids, polyphenols and alkaloids from botanicals can be BBB‑permeable and have neuroprotective or neuromodulatory potential, a general context relevant to mushroom-derived compounds but not a direct efficacy claim for this product [7]. Specific clinical evidence for microdosing psilocybin, Lion’s Mane cognitive effects, or Chaga neuroactivity is not detailed in the provided reporting; therefore, available sources do not mention controlled trials or outcome data for this exact Neuro Gold mushroom formula [1] [7].
4. What does research say about phosphatidylserine — the other “NeuroGold” product?
Reporting about phosphatidylserine in the context of other branded brain supplements notes that phosphatidylserine has been used safely at doses up to 300 mg daily for up to six months (discussion of Neuriva and ingredients) [8]. The NeuroGold-branded PS product is listed at 100 mg per softgel [2] [3]. The dataset provides safety dosing context but does not supply clinical efficacy trials specific to the PipingRock NeuroGold PS product; therefore, available sources do not mention randomized trial results for that specific bottle [8] [2].
5. Safety, legality and consumer cautions — what the sources imply
The mushroom product contains Psilocybe cubensis [1]; this species contains psilocybin, a psychedelic compound that is controlled or regulated in many jurisdictions. The provided sources do not detail legal status or safety warnings specific to the product pages, nor do they cite clinical safety data for this capsule; therefore, available sources do not mention jurisdictional legality, recommended medical supervision, or adverse-event statistics for the Neuro Gold mushroom capsules [1]. The PS softgel listing notes soy ingredients and excipients that may matter for allergies [2] [3]. The Manuka honey nerve product makes mechanistic claims about MMP‑13 and myelin repair on its site, but no external clinical evidence is provided in the data set [4].
6. Competing perspectives and reporting limitations
Manufacturer sites present ingredient lists and marketing claims for their own products [1] [4], while a consumer-review or product-review site offers user impressions and ratings for a “Neuro-PS Gold” product but reports mixed personal reactions and price concerns [9]. Independent scientific context on BBB‑permeable natural molecules offers a plausible mechanistic background for why some botanicals are investigated for CNS effects, but that does not validate specific product claims without controlled trials [7]. The sources are fragmented: different products share the “NeuroGold” name across unrelated formulas, and independent, peer‑reviewed clinical evidence for these branded formulations is not present in the provided reporting [2] [1] [4] [7].
If you want, I can: (a) compile primary clinical studies on psilocybin microdosing, Lion’s Mane and phosphatidylserine from peer‑reviewed journals (not included in current search results), or (b) compare labeling and claims across the different NeuroGold-branded products in more detail using the sources you provided.